Short term cost effectiveness of a regional myocardial infarction network

Health Economics Review

Volumn 3, Issue 1, 2013, Pages 1-8

  Birkemeyer, Ralf ^a   Dauch, Anke ^b   Müller, Alfred ^c   Beck, Manfred ^d   Schneider, Henrik ^a   Ince, Hueseyin ^a   Jung, Werner ^b   Wahler, Steffen ^e  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^b SCHWARZWALD BAAR KLINIKUM   (Germany)

^c Analytic Services   (Germany)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^e Fachhochschule für Gesundheit und Medizin   (Germany)

Author keywords

Cost analysis; Cost effectiveness; Network; Primary PCI; STEMI

Indexed keywords

ANGIOPLASTY; ARTICLE; CONFIDENCE INTERVAL; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; GERMANY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; POPULATION RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; REIMBURSEMENT; RURAL AREA; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 84971255144     PISSN: None     EISSN: 21911991     Source Type: Journal    
DOI: 10.1186/2191-1991-3-10     Document Type: Article

References (28)

1. Birkemeyer R, Rillig A, Treusch F, Koch A, Miljak T, Meyerfeldt U, Kunze M, Jung W, Höher M: Abortion of myocardial infarction by primary angioplasty depends on preprocedural TIMI flow. EuroIntervention 2011, 6:854-859.
2. Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick H, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, vańt Hof A, Widimsky P, Zahger D: ESC guidelines fort he management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012, 33(20):2569-2619.
3. O'Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz CB, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso JE, Tracy CM, Woo YJ, Zhao DX: 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/ American Heart Association task force on practice guidelines. Circulation 2013, 127(4):529-555.
4. Nallamothu BK, Bates ER: Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol 2003, 92:824-826.
5. Betriu A, Masotti M: Comparison of mortality rates in acute myocardial infarction treated by percutanneous coronary intervention versus fibrinolysis. Am J Cardiol 2005, 95:100-101.
6. Nallamothu BK, Antman EM, Bates ER: Primary percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: does the choice of fibrinolytic agent impact on the importance of time-to-treatment? Am J Cardiol 2004, 94:772-774.
7. Boersma E: Does time matter? A pooled analysis of randomized clinical trals comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J 2006, 27:779-788.
8. Pinto DS, Kirtane AJ, Nallamothu BK, Murphy SA, Cohen DJ, Laham RJ, Cutlip DE, Bates ER, Frederick PD, Miller DP, Carrozza JP Jr, Antman EM, Cannon CP, Gibson CM: Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation 2006, 114:2019-2025.
9. Canto JG, Every NR, Magid DJ, Rogers WJ, Malmgren JA, Frederick PD, French WJ, Tiefenbrunn AJ, Misra VK, Kiefe CI, Barron HV: The volume of primary angioplasty procedures and survival after acute myocardial infarction national registry of myocardial infarction 2 investigators. N Engl J Med 2000, 342:1573-1580
10. Spaulding C, Morice MC, Lancelin B, El Haddad S, Lepage E, Bataille S, Tresca JP, Mouranche X, Fosse S, Monchi M, de Vernejoul N: Is the volume-outcome relation still an issue in the era of PCI with systematic stenting? Results of the greater Paris area PCI registry. Eur Heart J 2006, 27:1054-1060
11. Bauer T, Hoffmann R, Jünger C, Koeth O, Zahn R, Gitt A, Heer T, Bestehorn K, Senges J, Zeymer U: Efficacy of a 24-h primary percutaneous coronary intervention service on outcome in patients with ST elevation myocardial infarction in clinical practice. Clin Res Cardiol 2009, 98(3):171 -178
12. Kalla K, Christ G, Karnik R, Malzer R, Norman G, Prachar H, Schreiber W, Unger G, Glogar HD, Kaff A, Laggner AN, Maurer G, Mlczoch J, Slany J, Weber HS, Huber K, The Vienna STEMI Registry Group: Implementation of guidelines improves the standard of care: the viennesse registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI Registry). Circulation 2006, 113:2398-2405
13. Schneider H, Ince H, Rehders T, Körber T, Weber F, Kische S, Chatterjee T, Nienaber CA: Drip & Ship-Netzwerk. Treatment of acute ST elevation myocardial infarction in a regional network. Herz 2007, 32:635-640
14. Buchholz J, Naber CK, Budde T, Koslowski B, Hailer B, Jacksch R, Sabin G, Haude M, Erbel R: Für den Herzinfarktverbund Essen. STEMI network Essen - in hospital results. Herz 2008, 33(2):148-152
15. Hailer B, Naber CK, Koslowski B, Budde T, Jacksch R, Sabin G, Lange S, Erbel R, Herzinfarktverbund Essen: STEMI network Essen - results after 1 year. Herz 2008, 33:153-157.
16. Saia F, Marrozzini C, Ortolani P, Palmerini T, Guastaroba P, Cortesi P, Pavesi PC, Gordini G, Pancaldi LG, Taglieri N, di Pasquale G, Branzi A, Marzocchi A: Optimization of therapeutic strategies for ST-elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality. Heart 2009, 95:370-376
17. Widimsky P, Zelizko M, Jansky P, Tousek F, Holm F, Aschermann M: On behalf of the CZECH investigators. The incidence, treatment strategies and outcomes of acute coronary syndromes in the reperfusion network of different hospital types in the Czech Republic: results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry. Int J Cardiol 2007, 119:212-219
18. Birkemeyer R, Rillig A, Koch A, MiljakT, Kunze M, Meyerfeldt U, Steffen W, Soballa M, Ranke C, Prassler R, Benzing A, Jung W: Primary angioplasty for any patient with ST-elevation myocardial infarction? Guideline-adherent feasibility and impact on mortality in a rural infarction network. Clin Res Cardiol 2010, 99:833-840
19. De Boer MJ, van Hout BA, Liem AL, et al: A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction. Am J Card 1995, 76:830-833.
20. Suryapranata H, Ottervanger JP, Nibbering E, et al: Long term outcome and cost-effectiveness of stenting versus balloon angioplasty for acute myocardial infarction. Heart 2001, 85:667-671
21. Vańt Hof AW, Suryapranata H, de Boer MJ, et al: Costs of stenting for acute myocardial infarction. Lancet 1998, 351:1817-1821
22. Concannon TW, Kent DM, Normand SL, Newhouse JP, Griffith JL, Cohen J, Beshansky JR, Wong JB, Aversano T, Selker HP: Comparative effectiveness of ST-segment-elevation myocardial infarction regionalization strategies. Circ Cardiovasc Qual Outcomes 2010, 3:506-513.
23. Zijlstra F, Hoorntje JCA, De Boer MJ, Reiffers S, Miedema K, Ottervanger JP, Vańt Hof AWJ, Suryapranata H: Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999, 341:1413-1419.
24. Löwel H: Koronare Herzkrankheit und akuter Myokardinfarkt. In Gesundheitsberichterstattung des Bundes. Edited by Robert Koch-Institut. Themenheft 33; 2006.
25. Kuch B, Bolte HD, Hoermann A, Meisinger C, Loewel H: What is the real hospital mortality from acute myocardial infarction? Eur Heart J 2002, 23:714-720
26. Dixon T, Lim LL, Oldridge NB: The MacNew heart disease health-related quality of life instrument: reference data for users. Qual Life Res 2002, 11:173-183.
27. Xie J, Wu EQ, Zheng ZJ, Sullivan PW, Zhan L, Labarthe DR: Patient-reported health status in coronary heart disease in the United States: age, sex, racial and ethnic differences. Circulation 2008, 118:491-497.
28. Smith T, Jordaens L, Theuns D, van Dessel P, Wilde A, Hunink M: The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: an European analysis. Eur Heart J 2013, 34:211-219.